Search Results - Bruce Walcheck

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    iPSC-derived NK cells expressing high-affinity IgG Fc receptor fusion CD64/16A to mediate flexible, multi-tumor antigen targeting for lymphoma by Kate J. Dixon, Kristin M. Snyder, Melissa Khaw, Robert Hullsiek, Zachary B. Davis, Anders W. Matson, Soheila Shirinbak, Bryan Hancock, Ryan Bjordahl, Martin Hosking, Jeffrey S. Miller, Jeffrey S. Miller, Jeffrey S. Miller, Bahram Valamehr, Jianming Wu, Jianming Wu, Bruce Walcheck, Bruce Walcheck, Bruce Walcheck, Bruce Walcheck

    Published in Frontiers in Immunology (2024-07-01)
    Get full text
    Article


  2. 2

    Detection of Antibody-Dependent Cell-Mediated Cytotoxicity—Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Opti... by Judith Cruz Amaya, Bruce Walcheck, Julie Smith-Gagen, Vincent C. Lombardi, Dorothy Hudig

    Published in Antibodies (2023-06-01)
    Get full text
    Article


  3. 3

    508 IL-15-stimulated NK cell proliferation is greatly augmented by the anti-ADAM17 mAb Medi-1 and requires CD137 by Kate Dixon, Anders W Matson, Robert Hullsiek, Sam Wang, Ryan R Friess, Bruce Walcheck

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  4. 4

    Association between MICA polymorphisms, s-MICA levels, and pancreatic cancer risk in a population-based case-control study. by Guillaume Onyeaghala, John Lane, Nathan Pankratz, Heather H Nelson, Bharat Thyagarajan, Bruce Walcheck, Kristin E Anderson, Anna E Prizment

    Published in PLoS ONE (2019-01-01)
    Get full text
    Article


  5. 5

    Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells by Kristin M. Snyder, Robert Hullsiek, Hemant K. Mishra, Daniel C. Mendez, Yunfang Li, Allison Rogich, Dan S. Kaufman, Jianming Wu, Bruce Walcheck

    Published in Frontiers in Immunology (2018-12-01)
    Get full text
    Article


  6. 6

    iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting by Jeffrey S Miller, Martin Hosking, Ryan Bjordahl, Bahram Valamehr, Soheila Shirinbak, Zachary Davis, Bryan Hancock, Bruce Walcheck, Kristin M Snyder, Kate J Dixon, Geoffrey Hart, Melissa Khaw, Anders Matson, Jianming Wu

    Published in Journal for ImmunoTherapy of Cancer (2023-12-01)
    Get full text
    Article


  7. 7

    Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells by Jeffrey S Miller, Martin Felices, Shee Kwan Phung, Anders W Matson, Sam Wang, Ryan R Friess, Bruce Walcheck, Kate J Dixon, Jianming Wu, Rob Hullsiek, Anders J Lindstedt, Tanya S Freedman, Emily N Truckenbrod

    Published in Journal for ImmunoTherapy of Cancer (2024-07-01)
    Get full text
    Article


  8. 8

    Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes by Amy W Ku, Jason B Muhitch, Colin A Powers, Michael Diehl, Minhyung Kim, Daniel T Fisher, Anand P Sharda, Virginia K Clements, Kieran O'Loughlin, Hans Minderman, Michelle N Messmer, Jing Ma, Joseph J Skitzki, Douglas A Steeber, Bruce Walcheck, Suzanne Ostrand-Rosenberg, Scott I Abrams, Sharon S Evans

    Published in eLife (2016-12-01)
    Get full text
    Article


Search Tools: